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and gastrointestinal microflora in broilers challenged with Campylobacter jejuni
1,

1

2

3

4

Hossein EBRAHIMI *, Shaban RAHIMI , Pejvak KHAKI , Jesse L. GRIMES , Sophia KATHARIOU
1
Department of Poultry Science, Faculty of Agriculture, Tarbiat Modares University, Tehran, Iran
2
Department of Microbiology and Leptospira Reference Laboratory, Razi Vaccine and Serum Research Institute, Karaj, Iran
3
Prestage Department of Poultry Science, College of Agriculture and Life Sciences, North Carolina State University, Raleigh, NC, USA
4
Department of Food Science, Bioprocessing, and Nutrition Sciences, North Carolina State University, Raleigh, NC, USA
Received: 18.02.2015

Accepted/Published Online: 31.01.2016

Final Version: 07.04.2016

Abstract: Campylobacter jejuni, a zoonotic bacterial pathogen with worldwide distribution, infects about 400 million humans in the
world annually. In order to reduce C. jejuni colonization in the gastrointestinal tracts of broilers and make chickens less susceptible
to colonization, four commercial products based on organic acid, probiotics, and medicinal plants were used. In this experiment, 210
one-day-old male broiler chicks (Ross 308) were assigned to 7 treatment groups randomly with 3 replications and 10 birds in each pen.
Birds were challenged on day 21 by 1 mL of 6 × 107 CFU/mL C. jejuni live suspension and samples were collected on days 28 and 42. The
immune system’s efficiency was evaluated by lymphoid organ development assessment and two specific and nonspecific immune system
tests. The cecal contents and liver were considered for C. jejuni enumeration. According to the results, all treatments except one showed
a significant difference from the control in terms of cecal colonization (P ≤ 0.001). Probiotic and Echinacea purpurea treatments could
significantly increase the immune system’s efficiency (P ≤ 0.001). In general, in this study we provide evidence that some commercial
feed and water additives can reduce chickens’ susceptibility to C. jejuni colonization and also can effectively increase immune system
efficiency.
Key words: Broilers, Campylobacter jejuni, colonization, Echinacea purpurea, organic acid, probiotics

1. Introduction
Campylobacter spp., mainly Campylobacter jejuni
and Campylobacter coli, are the most widely reported
bacteria around the world that cause human foodborne
infections (1). These bacteria are responsible for intestinal
infections in developed countries. Additionally, C. jejuni
is the most commonly known prior infection in patients
with Guillain–Barré syndrome, a severe inﬂammatory
polyneuropathy. Epidemiological studies have proved that
poultry and poultry products are the main source of human
infection by Campylobacter (2). Accordingly, it becomes
essential to control the viable numbers of Campylobacter
in poultry products. Seemingly, hygiene and biosecurity
efforts aimed at minimizing Campylobacter-contaminated
poultry are not very effective. The most interesting aspect
of Campylobacter pathogenesis is its capability to invade
chicken immune responses, although it heavily colonizes
(up to 109 bacteria/g) chickens’ intestinal mucosa (3).
On the other hand, antibiotic abuse causes a serious
medicinal problem and increase in the incidence of
* Correspondence: hosseyn.ebrahimi@yahoo.com

resistant Campylobacter strains significantly impairs the
process of combating campylobacteriosis by prolonging
therapy or rendering it ineffective (4). Therefore, several
studies and experiments have been implemented to
reduce the quantity of Campylobacter in poultry through
nonantibiotic approaches over the past few years. These
include vaccination (5), feeding chickens bacteriophages
and bacteriocins, and various efforts to reduce
Campylobacter by applying feed and water additives such
as organic acids and their derivatives, medium-chain
fatty acids, and probiotics. Although there is no specified
or reliable plan to control Campylobacter colonization
in the poultry gastrointestinal tract, there are signs of
hope that reduction of Campylobacter colonization in
the poultry gastrointestinal tract can reduce probability
of contamination of poultry meat during slaughter and
dressing. It is expected that a 2-log decline in C. jejuni
populations on poultry carcasses could cause about a 30fold reduction in human campylobacteriosis cases (6).
Among other alternatives, applications of organic acids
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and especially medium-chain fatty acids, probiotics (7),
and medicinal plants have been shown to seemingly be an
efficient approach to control Campylobacter.
The beneficial properties of probiotics and their effects
on animal health and reduction of pathogens in the food
chain have increasingly been highlighted in the past
years. It has been reported that bacteria, and especially
lactobacilli, could possess inhibitory characteristics
against Campylobacter spp. (7). Short-chain fatty acids
have been widely used to prevent pathogenic bacteria
in food products. Fatty acids diffuse the bacteria in the
undissociated form and dissociate in the protoplasm,
causing intracellular acidification (8). Campylobacter’s
susceptibility to the acidic condition has been shown in
several studies and this characteristic has been used in
different approaches to reduce the gastrointestinal tract’s
pH in order to control Campylobacter colonization.
Medicinal plant extracts have antimicrobial, antiviral,
anthelminthic, and antioxidative properties and they
are known to aid the endocrine and immune systems
(9). Accordingly, the dual actions of Echinacea purpurea
(EP) in the eradication of bacteria and reversal of
their antioxidative activities would assist in combating
infections (10). Overall, EP has shown a strong capability
to stimulate the immune system, this stimulation leading
to production of more immune system cells (11). Hence,
in this study, we evaluate four commercial products based
upon organic acids, probiotics, and a medicinal plant to
see their effects on broilers’ cecal microbial populations
and immune response and especially their capability
to reduce Campylobacter colonization in the broilers’
gastrointestinal tract.
2. Materials and Methods
2.1. Birds and experimental design
A total of 210 one-day-old male broilers (Ross 308) were
obtained from a local commercial hatchery (Kosar, Karaj,
Iran). Chicks were reared on wood shaving litter in a
completely randomized design in separated pens at the
Poultry Research Center of the Faculty of Agriculture,
Tarbiat Modares University, Tehran, Iran. Feed and
nonchlorinated water were supplied ad libitum throughout
the study and all birds received the same amount of a certain
diet based on corn and soybean. Birds were assigned to 7
treatment groups with 3 replicate pens/treatment and 10
birds/pen. The transmission of Campylobacter between
pens was largely prevented by the hygienic procedures
during the experiment. The treatments were as follows:
organic acid (Selko-pH®) in drinking water (1 mL in 1 L
for 2 weeks, and 7–8 h for the rest of the growth period)
(Group OA); organic acid (Selko-pH®) in drinking water
for 12 h before slaughter (1/1000 (v/v)) (Group OA2);
protected organic acid and butyric acid glycerides (Baby
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C4®) at 2.5/1 g kg–1 mixed in the feed 12 h before slaughter
(Group POA); water-soluble and mix-in probiotic feed
(Primalac®, Star Labs, Clarksdale, MO, USA) (in drinking
water: 120/1 g/L until day 14, mixed in feed: 454/1000 g/kg
until day 28 and 225/1000 g/kg for the rest of the growth
period) (Group PM); Echinacea purpurea alcoholic extract
in drinking water (1 mL in 1 L for 2 weeks, and 7–8 h for
the rest of the growth period) (Group EP); and two groups
considered as a negative control (NC, not challenged) and
a positive control (PC, bacterially challenged).
2.2. Bacteria preparation and Campylobacter challenge
The bacterial isolate C. jejuni RTCC 1097 was used for
experimental challenge (provided by the Razi Vaccine
and Serum Research Institute, Karaj, Iran). This strain was
originally isolated from the cloaca of a local commercial
broiler chicken. The bacterium was cultured onto
Campylobacter selective agar (Oxoid, UK) with 10%
sheep blood and incubated at 42 °C in microaerophilic
conditions (7% CO2, 10% H2, and 80% N2, produced by the
Anaxomat System, Mart Microbiology, Lichtenvoorde, the
Netherlands) for 48–72 h. After 48 h of incubation at 42
°C, the majority of C. jejuni strains produced gray, moist,
flat, and spreading colonies on the agar. The bacteria
were harvested and diluted in PBS to the specific viable
concentration (6 × 107 CFU/mL) (12). The inoculum
concentration was estimated by MacFarlane tubes. The
inoculum was kept on ice for less than 1 h previous to
oral gavage (inoculation in crop) of chicks. On day 21,
except for the negative control group that received 1.0 mL
of sterile PBS, the rest of the birds were orally challenged
with a 1.0-mL dose of the inoculum (12).
2.3. Sampling
On days 28 and 42, six birds per treatment (two per pen)
were euthanized by cervical dislocation and then cecal
contents and blood and liver samples were collected and
the relative weights of lymphoid organs (bursa of Fabricius,
spleen, and liver) were measured. Cecal contents (1 g) were
suspended in 9 mL of PBS. Serial dilutions were prepared
in saline from 10–1 to 10–7. Afterwards, 10 µL of the last
dilutions were spread onto 9-cm plates contain C. jejuni
specific medium (Campylobacter Agar Base, Oxoid) with
10% sheep blood according to standard bacteriological
procedures. Plates were incubated under microaerophilic
conditions (microaerophilic conditions were created with
the Anaxomat System, 7% CO2, 10% H2, and 80% N2) for
24–48 h, until colonies were visible and large enough to be
counted. To evaluate the cecal quantity of lactobacilli and
total bacteria, 0.1 mL of the last dilution was also cultured
on selective lactobacilli medium (Rogosa Agar, Oxoid)
and trypticase soy agar (Oxoid) by pour plate method,
and then both of them were incubated for 72 h and 48 h,
respectively.
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Liver samples were stored in sterile petri dishes and
transferred to the laboratory for microbiological analysis.
The middle part of the liver after scorching the surface of
samples was used for bacterial analysis and then 1 g of the
internal part was macerated, transferred into 9 mL of PBS,
and completely homogenized by vortexing. Serial dilutions
were prepared in saline from 10–1 to 10–3 and then sample
culturing and enumeration were conducted as mentioned
above.
2.4. Sheep red blood cell (SRBC) injections
On days 24 and 31, a SRBC suspension (5% V:V in sterile
PBS), which was provided in the laboratory (Tarbiat
Modares University, Faculty of Agriculture, Tehran, Iran),
was injected into the breast muscles of six birds (2 from
each pen). One week later, blood samples were taken via
wing vein on day 38. Thereafter, antibody titration against
SRBC was done by hemagglutination inhibition (HI)
test. Antibody titers were expressed as the log-2 of the
reciprocal of the highest serum dilution giving complete
agglutination.
2.5. Heterophil to lymphocyte ratio (H/L)
Blood samples were collected from wing veins within 1
min after capturing each bird and then transferred into
test tubes containing ethylene diamine tetraacetic acid
(EDTA) as an anticoagulant. A blood smear was prepared
using May–Grünwald–Giemsa stain and the number of
heterophils (H) to lymphocytes (L) was counted for a total
of 100 cells (13). The counting results were converted to a
ratio of H/L and introduced as a percent.

2.6. Statistical analysis
The experimental design was a completely randomized
design including 7 treatments and 3 replications. All data
were subjected to SPSS 17 (SPSS Inc., Chicago, IL, USA)
for analyzing variances and Duncan’s multiple range test
was used for comparison of means.
3. Results
As a result of this study (Figures 1 and 2), the number of
lactobacilli was significantly increased in the PM and OA
treatments (P ≤ 0.05). At day 28, the number of lactobacilli
in the PM treatment was significantly higher than in the
positive control (P ≤ 0.05). This enhancement was not seen
at day 42.
The data of enumeration of Campylobacter cecal content
obviously showed that the number of Campylobacter in
the OA, PM, POA, and EP treatments was significantly
decreased (P ≤ 0.001) (Figures 1 and 2). The positive
control and PM treatment (probiotics) had the highest and
lowest C. jejuni cecal and liver colonization, respectively
(Figure 3). Campylobacter content in the liver also showed
that all treatments could not significantly reduce the
quantity of Campylobacter in the liver (Figure 3).
The improvement of antibody concentration in
response to SRBCs and gain in spleen, bursa of Fabricius,
and liver weights of broilers are presented in Figure 4
and the Table, respectively. Our findings showed that
the relative weight of the spleen and bursa of Fabricius
was only higher in the EP treatment compared with the

Figure 1. The number of Campylobacter jejuni, Lactobacillus, and total count of bacteria in the cecum at the first sampling point (day 28).
OA: Organic acid (Selko-pH®) in drinking water; PM: water-soluble and mix-in feed probiotic (Primalac®); EP: Echinacea purpurea
alcoholic extract in drinking water; POA: protected organic acid and butyric acid glycerides (Baby C4®); OA2: organic acid (Selko-pH®)
in drinking water for 12 h before slaughter; PC: positive control (bacterially challenged); NC: negative control (not challenged).
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Figure 2. The number of Campylobacter jejuni, Lactobacillus, and total count of bacteria in the cecum at the first sampling point (day 42).
OA: Organic acid (Selko-pH®) in drinking water; PM: water-soluble and mix-in feed probiotic (Primalac®); EP: Echinacea purpurea
alcoholic extract in drinking water; POA: protected organic acid and butyric acid glycerides (Baby C4®); OA2: organic acid (Selko-pH®)
in drinking water for 12 h before slaughter, PC: positive control (bacterially challenged), NC: negative control (not challenged) (P ≤
0.001).

Figure 3. Campylobacter jejuni (CFU per gram of liver) in the liver on days 28 (liver 1) and 42 (liver 2).
OA: Organic acid (Selko-pH®) in drinking water; PM: water-soluble and mix-in feed probiotic (Primalac®); EP: Echinacea purpurea
alcoholic extract in drinking water; POA: protected organic acid and butyric acid glycerides (Baby C4®); OA2: organic acid (Selko-pH®)
in drinking water for 12 h before slaughter, PC: positive control (bacterially challenged), NC: negative control (not challenged) (P ≤
0.001).

positive control (P ≤ 0.001). In addition, there were no
significant differences among all treatments in terms of
liver relative weight.
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In order to evaluate the specific and nonspecific
immune systems of the broilers, two immune assessment
tests including SRBCs (a specific immune system indicator)
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Figure 4. Titers of SRBC agglutinins, determined by doubling dilutions (log-2).
OA: Organic acid (Selko-pH®) in drinking water; PM: water-soluble and mix-in feed probiotic (Primalac®); EP: Echinacea purpurea
alcoholic extract in drinking water; POA: protected organic acid and butyric acid glycerides (Baby C4®); OA2: organic acid (Selko-pH®)
in drinking water for 12 h before slaughter, PC: positive control (bacterially challenged), NC: negative control (not challenged) (P ≤
0.001).

Table. The relative weight of lymphoid organs (spleen, bursa of Fabricius, and liver) on days 28 and 42.

Treatment

Spleen

Bursa of Fabricius

Liver

28

42

28

42

28

42

OA

0.11 ± 0.002

0.11 ± 0.001

0.16 ± 0.010

0.13 ± 0.004

2.42 ± 0.13

2.21 ± 0.12

PM

0.11 ± 0.002

0.11 ± 0.002

0.16 ± 0.014

0.13 ± 0.001

2.34 ± 0.10

2.20 ± 0.10

EP

0.14 ± 0.006

0.14 ± 0.003

0.19 ± 0.004

0.14 ± 0.004

2.50 ± 0.06

2.33 ± 0.16

POA

0.08 ± 0.006

0.10 ± 0.001

0.14 ± 0.009

0.13 ± 0.005

2.29 ± 0.09

2.23 ± 0.04

OA2

0.09 ± 0.007

0.10 ± 0.001

0.14 ± 0.009

0.13 ± 0.005

2.31 ± 0.10

2.24 ± 0.04

PC

0.09 ± 0.001

0.10 ± 0.001

0.15 ± 0.007

0.13 ± 0.004

2.36 ± 0.17

2.39 ± 0.12

NC

0.11 ± 0.001

0.11 ± 0.002

0.16 ± 0.016

0.12 ± 0.009

2.40 ± 0.10

2.21 ± 0.11

OA: Organic acid (Selko-pH®) in drinking water; PM: water-soluble and mix-in feed probiotic (Primalac®); EP: Echinacea purpurea
alcoholic extract in drinking water; POA: protected organic acid and butyric acid glycerides (Baby C4®); OA2: organic acid (Selko-pH®)
in drinking water for 12 h before slaughter, PC: positive control (bacterially challenged), NC: negative control (not challenged) (P ≤
0.001).

and heterophil and lymphocyte measurements were done.
The antibody production (SRBC) was significantly higher
in the EP treatment and PM in compared to the positive
control (P ≤ 0.001) (Figure 4).

Another factor that was measured to evaluate the
immune response was the H/L ratio. The results indicated
that the H/L ratio was significantly higher in the EP
treatment and PM as compared to the positive control (P
≤ 0.001) (Figure 5).
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Figure 5. Heterophil to lymphocyte ratios.
OA: Organic acid (Selko-pH®) in drinking water; PM: water-soluble and mix-in feed probiotic (Primalac®); EP: Echinacea purpurea
alcoholic extract in drinking water; POA: protected organic acid and butyric acid glycerides (Baby C4®); OA2: organic acid (Selko-pH®)
in drinking water for 12 h before slaughter, PC: positive control (bacterially challenged), NC: negative control (not challenged) (P ≤
0.001).

4. Discussion
The intestinal microbial flora of poultry is composed of
different varieties of bacteria. The majority of this flora
are lactic acid bacteria known as advantageous bacteria
by their production of organic acid. According to our
results PM and OA could significantly affect the number
of lactobacilli by day 42 but PM treatments did not show
a regular increase. This might be due to the fact that
the number of bacteria reached saturation level as birds
matured. This was observed while the OA treatment
indicated higher numbers of lactobacilli bacteria at both
day 28 and 42. It also could be due to lactobacilli exclusively
excelling at colonization in low pH conditions compared
with other kinds of competing bacteria.
All treatments except OA2 could effectively reduce the
number of Campylobacter in the cecum but they had no
effect on the Campylobacter content of the liver. This can
be a result of the feed additives’ direct and limited effect
only on the gastrointestinal contents. It has been shown
that there is a direct correlation between the intestinal
contents of Campylobacter and the amount of translocation
of bacterium to the spleen and liver, so we expected to see
a significant decrease in the liver as well.
The main bacteria used in the probiotic (Primalac)
included Lactobacillus and Biﬁdobacterium. The results
from the in vitro experiment showed that Lactobacillus
and Biﬁdobacterium strains and also some strains of
Enterococcus faecium have antagonistic action against
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C. jejuni, and noticeable decrease has been seen in the
amount of C. jejuni with inhibitory and antimicrobial
activity (7). The bactericidal effect against Campylobacter
probably results from the production of organic acids,
as already evidenced. Other studies indicated that this
inhibitory activity might be due to the production of a
proteinaceous molecule (13). Results from this study are
in agreement with the results of experiments using similar
probiotics in order to control Campylobacter colonization
(14). Many in vitro studies have shown that Campylobacter
spp. have a hypersensitivity to low pH conditions (15). The
host animal might be less susceptible to Campylobacter
colonization due to acidiﬁcation of the drinking water. The
basis of this is that the gastrointestinal tract of chickens
becomes more acidic when the animals receive acidized
drinking water. This might reduce the number of bacteria
that reach the lower parts of the gastrointestinal tract. It is
also possible that the acid used in drinking water changes
the intestinal microflora, similar to a pre- or probiotic,
decreasing enteric Campylobacter content. A recent study
showed that using organic acids in drinking water can
reduce bacteria in the fecal content of pigs (16). In another
study, it was shown that chickens fed with acidized feed
are less susceptible to infection with Campylobacter (17). It
has been shown that the use of acetic, lactic, or formic acid
in the drinking water of market-age broilers significantly
reduced crop pH and decreased the total quantity of
Salmonella and Campylobacter in the broiler carcasses at
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processing (18). Between two acidic feed (POA) and water
additive (OA2) treatments that were administrated at 12
h before slaughter, only POA significantly reduced the
number of viable Campylobacter. Campylobacter is able to
modulate gene activities, which allows quick adaptation
of the microorganism to new environmental conditions
(19). Results also suggest that the ability to create biofilms
might be a key factor for chicken colonization (20). Using
a cross-sectional approach to reduce the number of viable
Campylobacter thus seems to be feasible. Regarding the
fact that Campylobacter spp. have high sensitivity to
acidic conditions, using acidified nutrition a few hours
before slaughter could be an effective way to reduce the
number of viable Campylobacter in the gastrointestinal
tract. The antimicrobial properties of n-butyric acid and
its derivatives against Salmonella Typhimurium and
Clostridium perfringens were studied and it was revealed
that n-butyric acid and its derivatives (monobutyrin and
a combination of mono-, di-, and triglycerides of butyric
acid) were able to reduce pathogenic bacteria (21). It
seems that the C. jejuni reduction in the POA treatment
was related to effective transmission of n-butyric acid and
its derivatives in the gastrointestinal tract by protection.
According to the positive effect of OA on the reduction of
Campylobacter, the nonsignificant results of OA2 could be
due to the short time of administration and the weakness
of this product in reducing intestinal pH.
Echinacea spp. contains four major groups of
compounds that could possibly be responsible for an
enhancement of the immune response (22) Glycoproteins,
polysaccharides, caffeic acid conjugates (caftaric acid,
cichoric acid, and echinacoside) as well as alkyl amides
(2-ene and 2,4-dienes) are commonly found in Echinacea
species (23). Most of these components have been
investigated for their immunomodulating potential,
and many have been found to enhance macrophage
activity (24). These components induce some alterations
in NFκB levels. NFκB is a nuclear transcription factor
that stimulates the expression of several genes including
key components of the inflammatory response such
as TNFα, IL-1, chemokines, adhesion molecules,
and cyclooxygenase-2 (25). Many studies have been
conducted in order to investigate the antibiotic activity
and it was generally found that Echinacea purpurea has
antibiotic and immunostimulant properties (22). In the
case of poultry, studies have mentioned that Echinacea
purpurea can promote poultry’s immune system efficiency
(26,27). It has been shown that using EP root extract as a
dietary supplement significantly decreased lesions in the
intestines of poultry contaminated with the protozoan

parasite Coccidia. It also enhanced the health of the birds
in comparison with controls (26).
The immunostimulant property of Echinacea spp. has
been mentioned in many studies and this characteristic
probably made the lymphoid organs more active.
Furthermore, it has been proven that administration of
Echinacea purpurea can increase spleen cells’ angiogenic
activity (28).
Because of the specific function of the lymphoid
organs, they are susceptible to oxidative injury, and
the antioxidant activities of EP probably protected
these organs from oxidative injuries and may allow
antibody-producing organs to do their functions more
efficiently. Allen found that EP can promote the immune
response to live vaccination and may provide protective
immunostimulation in the incidence of the natural
coccidian inhabitants in the litter (26). Böhmer et al.
showed same results in the case of ascending antibody
titers against SRBCs in broilers using EP for immune
system enhancement (10). Moreover, it has been indicated
that lactobacilli possess the capability to persist in the
intestinal tract and can act as adjuvants to the humoral
immune response (29). This could be related to the
increasing activities of antibody-producing cells, which
might have been stimulated by the probiotic organism.
Khaksefidi et al. reported that antibody production
against Newcastle disease virus in the 50 mg/kg probioticsupplemented group increased signiﬁcantly at 10 days after
immunization compared to the control. They also showed
that the probiotic had a positive effect on production and
durability of antibodies in response to SRBC antigens (30).
Several strains of live lactobacilli have been shown to
provoke the release of proinﬂammatory cytokines, TNFα,
and IL-6, and they can stimulate nonspecific immunity (30).
In addition, direct-fed microbial supplements increased
spontaneous as well as antigen-specific spleen lymphocyte
proliferation in chickens, a surrogate marker of increased
cellular immunity. As mentioned before, Echinacea spp.
has positive effects on the entire immune system and can
be traceable both in specific and nonspecific immune
responses. This finding of the current study is consistent
with those of Böhmer et al., who found that ethanolic juice
of Echinacea increased the number of lymphocytes and
total leukocytes in hens and pigs significantly (10).
In conclusion, in this study we provide evidence that
a specific probiotic, organic acid, and Echinacea purpurea
as a medicinal plant can reduce chickens’ susceptibility to
C. jejuni colonization and can also effectively reduce the
extent of C. jejuni colonization by their effect on microflora
and chickens’ immune system efficiency.

335

EBRAHIMI et al. / Turk J Vet Anim Sci
References
1.

Yang X, Kirsch J, Simonian A. Campylobacter spp. detection in
the 21st century: a review of the recent achievements in biosensor
development. J Microbiol Methods 2013; 95: 48–56.

2.

Kramer JM, Frost JA, Bolton FJ, Wareing DR. Campylobacter
contamination of raw meat and poultry at retail sale:
identification of multiple types and comparison with isolates
from human infection. J Food Protect 2000; 63: 1654–1659.

3.

Achen M, Morishita TY, Ley EC. Shedding and colonization of
Campylobacter jejuni in broilers from day-of-hatch to slaughter
age. Avian Dis 1998; 42: 732–737.

4.

Moore JE, Barton MD, Blair IS, Corcoran D, Dooley JS, Fanning S,
Kempf I, Lastovica AJ, Lowery CJ, Matsuda M. The epidemiology
of antibiotic resistance in Campylobacter. Microbes Infect 2006;
8: 1955–1966.

16.

De Busser EV, Dewulf JL, Zutter D, Haesebrouck F, Callens J,
Meyns T, Maes W, Maes D. Effect of administration of organic
acids in drinking water on faecal shedding of E. coli, performance
parameters and health in nursery pigs. Vet J 2011; 188: 184–188.

17.

Heres L, Engel B, Urlings H, Wagenaar J, Van Knapen F. Effect
of acidified feed on susceptibility of broiler chickens to intestinal
infection by Campylobacter and Salmonella. Vet Microbiol 2004;
99: 259–267.

18.

Byrd J, Hargis B, Caldwell D, Bailey R, Herron K, McReynolds J,
Brewer R, Anderson R, Bischoff K, Callaway T. Effect of lactic acid
administration in the drinking water during preslaughter feed
withdrawal on Salmonella and Campylobacter contamination of
broilers. Poultry Sci 2001; 80: 278–283.

19.

Gaynor EC, Cawthraw S, Manning G, MacKichan JK, Falkow S,
Newell DG. The genome-sequenced variant of Campylobacter
jejuni NCTC 11168 and the original clonal clinical isolate differ
markedly in colonization, gene expression, and virulenceassociated phenotypes. J Bacteriol 2004; 186: 503–517.

5.

Jagusztyn-Krynicka EK, Łaniewski P, Wyszyńsk A. Update on
Campylobacter jejuni vaccine development for preventing human
campylobacteriosis. Expert Rev Vaccines 2009; 8: 625–645.

6.

Rosenquist H, Nielsen NL, Sommer HM, Nørrung B, Christensen
BB. Quantitative risk assessment of human campylobacteriosis
associated with thermophilic Campylobacter species in chickens.
Int J Food Microbiol 2003; 83: 87–103.

20.

Kalmokoff M, Lanthier P, Tremblay TL, Foss M, Lau PC, Sanders
G, Austin J, Kelly J, Szymanski CM. Proteomic analysis of
Campylobacter jejuni 11168 biofilms reveals a role for the motility
complex in biofilm formation. J Bacteriol 2006; 188: 4312–4320.

7.

Santini C, Baffoni L, Gaggia F, Granata M, Gasbarri R, Di Gioia
D, Biavati B. Characterization of probiotic strains: An application
as feed additives in poultry against Campylobacter jejuni. Int J
Food Microbiol 2010; 141: S98–S108.

21.

Namkung H, Yu H, Gong J, Leeson S. Antimicrobial activity
of butyrate glycerides toward Salmonella Typhimurium and
Clostridium perfringens. Poultry Sci 2011; 90: 2217–2222.

8.

Sun CQ, O’Connor CJ, Turner SJ, Lewis GD, Stanley RA, Roberton
AM. The effect of pH on the inhibition of bacterial growth by
physiological concentrations of butyric acid: implications for
neonates fed on suckled milk. Chem Biol Interact 1998; 113:
117–131.

22.

Matthias A, Banbury L, Bone KM, Leach DN, Lehmann RP.
Echinacea alkylamides modulate induced immune responses in
T-cells. Fitoterapia 2008; 79: 53–58.

23.

Woelkart K, Bauer R. The role of alkamides as an active principle
of Echinacea. Planta Med 2007; 73: 615–623.

24.

Goel V, Chang C, Slama JV, Barton R, Bauer R, Gahler R, Basu
TK. Alkylamides of Echinacea purpurea stimulate alveolar
macrophage function in normal rats. Int Immunopharmacol
2002; 2: 381–387.

25.

Pragathi D, Vijaya T, Anitha D, Mouli K, Sai Gopal D. Botanical
immunomodulators-potential therapeutic agents. Journal of
Global Pharma Technology 2011; 3: 1–14.

26.

Allen PC. Dietary supplementation with Echinacea and
development of immunity to challenge infection with coccidia.
Parasitol Res 2003; 91: 74–78.

27.

Dehkordi SH, Fallah V, Dehkordi SH. Enhancement of broiler
performance and immune response by Echinacea purpurea
supplemented in diet. Afr J Biotechnol 2011; 10: 11280–11286.

28.

Skopińska-Różewska E, Sommer E, Bałan BJ, Borowska A,
Radomska-Leśniewska D. The in vivo effect of dry hydroalcoholic extract of Echinacea purpurea on angiogenic activity of
human blood mononuclear cells. Cent Eur J Immunol 2010; 35:
223–226.

9.

Dahiya J, Wilkie D, Van Kessel A, Drew M. Potential strategies
for controlling necrotic enteritis in broiler chickens in postantibiotic era. Anim Feed Sci Tech 2006; 129: 60–88.

10.

Böhmer BM, Salisch H, Paulicks BR, Roth F. Echinacea purpurea
as a potential immunostimulatory feed additive in laying hens
and fattening pigs by intermittent application. Livest Sci 2009;
122: 81–85.

11.

Hudson JB. Applications of the phytomedicine Echinacea
purpurea (purple coneflower) in infectious diseases. J Biomed
Biotechnol 2012; 2012: 769896.

12.

Lamb-Rosteski JM, Kalischuk LD, Inglis GD, Buret AG.
Epidermal growth factor inhibits Campylobacter jejuni-induced
claudin-4 disruption, loss of epithelial barrier function, and
Escherichia coli translocation. Infect Immun 2008; 76: 3390–
3398.

13.

Gross W, Siegel H. Evaluation of the heterophil/lymphocyte ratio
as a measure of stress in chickens. Avian Dis 1983; 27: 972–979.

14.

Willis W, Reid L. Investigating the effects of dietary probiotic
feeding regimens on broiler chicken production and
Campylobacter jejuni presence. Poultry Sci 2008; 87: 606–611.

29.

Fang H, Elina T, Heikki A, Seppo S. Modulation of humoral
immune response through probiotic intake. FEMS Immunol
Med Microbiol 2000; 29: 47–52.

15.

Netten PV, Veld J, Mossel D. The immediate bactericidal effect of
lactic acid on meat‐borne pathogens. J Appl Microbiol 1994; 77:
490–496.

30.

Khaksefidi A, Ghoorchi T. Effect of probiotic on performance
and immunocompetence in broiler chicks. J Poult Sci 2006; 43:
296–300.

336

